Limits...
A history of the term "DMARD".

Buer JK - Inflammopharmacology (2015)

Bottom Line: It then examines the usage of the terms "remission-inducing drugs" (RIDs) and "slow-acting anti-rheumatic drugs" (SAARDs), which for some years offered competition to the term DMARDs, thus underscoring the contingency of the establishment of DMARD as a word.Finally, it juxtaposes the apparently spontaneous emergence of the three terms DMARD, SAARD and RID, and the disappearance of the latter two, with a failed attempt in the early 1990s to replace these terms with the new term "disease-controlling antirheumatic treatment" (DC-ART).The analysis highlights the paradoxical qualities of the DMARD concept as robust albeit tension ridden, while playing down the role of identified individuals and overarching explanations of purpose.

View Article: PubMed Central - PubMed

Affiliation: Department of Social Anthropology, University of Oslo, Blindern, Postboks 1091, 0317, Oslo, Norway, j.k.buer@sai.uio.no.

ABSTRACT
The article outlines a history of the concept of "disease-modifying antirheumatic drugs" or DMARDs--from the emergence in the 1970s of the idea of drugs with decisive long-term effects on bone erosion in rheumatoid arthritis (RA), through the consolidation and popularisation in the term DMARD in 1980s and 1990s. It then examines the usage of the terms "remission-inducing drugs" (RIDs) and "slow-acting anti-rheumatic drugs" (SAARDs), which for some years offered competition to the term DMARDs, thus underscoring the contingency of the establishment of DMARD as a word. Finally, it juxtaposes the apparently spontaneous emergence of the three terms DMARD, SAARD and RID, and the disappearance of the latter two, with a failed attempt in the early 1990s to replace these terms with the new term "disease-controlling antirheumatic treatment" (DC-ART). The analysis highlights the paradoxical qualities of the DMARD concept as robust albeit tension ridden, while playing down the role of identified individuals and overarching explanations of purpose.

No MeSH data available.


Related in: MedlinePlus

Fries, title page, first title containing acronym DMARD. With permission from Fries (1990), The Journal of Rheumatology
© Copyright Policy - OpenAccess
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4508364&req=5

Fig3: Fries, title page, first title containing acronym DMARD. With permission from Fries (1990), The Journal of Rheumatology

Mentions: The next publication in which title the term DMARD figures as acronym marks a more significant beginning. This was the article “Safety issues related to DMARD therapy” (Fries 1990, see Fig. 3), which was followed shortly by “Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD Registry” (Matteson et al. 1991). From that moment and throughout the 1990s and 2000s, the use of the acronym DMARD in the titles of scientific publications multiplied. A PubMed search on 17.12.2014 identified 273 such titles. A Google search for the word4 gave 475,000 results.Fig. 3


A history of the term "DMARD".

Buer JK - Inflammopharmacology (2015)

Fries, title page, first title containing acronym DMARD. With permission from Fries (1990), The Journal of Rheumatology
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4508364&req=5

Fig3: Fries, title page, first title containing acronym DMARD. With permission from Fries (1990), The Journal of Rheumatology
Mentions: The next publication in which title the term DMARD figures as acronym marks a more significant beginning. This was the article “Safety issues related to DMARD therapy” (Fries 1990, see Fig. 3), which was followed shortly by “Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD Registry” (Matteson et al. 1991). From that moment and throughout the 1990s and 2000s, the use of the acronym DMARD in the titles of scientific publications multiplied. A PubMed search on 17.12.2014 identified 273 such titles. A Google search for the word4 gave 475,000 results.Fig. 3

Bottom Line: It then examines the usage of the terms "remission-inducing drugs" (RIDs) and "slow-acting anti-rheumatic drugs" (SAARDs), which for some years offered competition to the term DMARDs, thus underscoring the contingency of the establishment of DMARD as a word.Finally, it juxtaposes the apparently spontaneous emergence of the three terms DMARD, SAARD and RID, and the disappearance of the latter two, with a failed attempt in the early 1990s to replace these terms with the new term "disease-controlling antirheumatic treatment" (DC-ART).The analysis highlights the paradoxical qualities of the DMARD concept as robust albeit tension ridden, while playing down the role of identified individuals and overarching explanations of purpose.

View Article: PubMed Central - PubMed

Affiliation: Department of Social Anthropology, University of Oslo, Blindern, Postboks 1091, 0317, Oslo, Norway, j.k.buer@sai.uio.no.

ABSTRACT
The article outlines a history of the concept of "disease-modifying antirheumatic drugs" or DMARDs--from the emergence in the 1970s of the idea of drugs with decisive long-term effects on bone erosion in rheumatoid arthritis (RA), through the consolidation and popularisation in the term DMARD in 1980s and 1990s. It then examines the usage of the terms "remission-inducing drugs" (RIDs) and "slow-acting anti-rheumatic drugs" (SAARDs), which for some years offered competition to the term DMARDs, thus underscoring the contingency of the establishment of DMARD as a word. Finally, it juxtaposes the apparently spontaneous emergence of the three terms DMARD, SAARD and RID, and the disappearance of the latter two, with a failed attempt in the early 1990s to replace these terms with the new term "disease-controlling antirheumatic treatment" (DC-ART). The analysis highlights the paradoxical qualities of the DMARD concept as robust albeit tension ridden, while playing down the role of identified individuals and overarching explanations of purpose.

No MeSH data available.


Related in: MedlinePlus